72 results
Page 2 of 4
8-K
EX-99.1
t23bu2e1u rq
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
8-K
EX-10.3
2p092h9d4 nkjou4s1b5
21 Jan 22
Entry into a Material Definitive Agreement
4:30pm
424B3
eif0vf 0q3y
14 Jan 22
Prospectus supplement
5:18pm
D
9husy2219epalcifjhb
3 Jan 22
$8.32M in equity / options / securities to be acquired, sold $2.2M, 12 investors
5:16pm
8-K
EX-10.1
hswvct
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
424B5
9aj36d 0xtlu9qisb5p
23 Dec 21
Prospectus supplement for primary offering
5:01pm
D
7gpy66edir4qijpns
3 Dec 21
$12.82M in equity / options / securities to be acquired, sold $3.54M, 12 investors
4:16pm
8-K
EX-10.1
9fkpjlsov2zgcx
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B5
fvgk2e
1 Dec 21
Prospectus supplement for primary offering
5:10pm
DEF 14A
4hv3na19kqpz5 qvo6dl
22 Nov 21
Definitive proxy
4:37pm
8-K
EX-99.1
01j4szbni5untnzc0g8
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am
D
tqqfc
26 Oct 21
$5.92M in options / securities to be acquired, 10 investors
1:39pm
8-K
EX-10.1
svr a48u9wk
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
b57a6tb5afokw
15 Oct 21
Prospectus supplement for primary offering
5:01pm